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Development of a multilevel intervention
to increase colorectal cancer screening in
Appalachia
Aaron J. Kruse-Diehr1,2* , Jill M. Oliveri3, Robin C. Vanderpool2, Mira L. Katz3,4, Paul L. Reiter4, Darrell M. Gray II3,5,
Michael L. Pennell4, Gregory S. Young5, Bin Huang2, Darla Fickle3, Mark Cromo2, Melinda Rogers2, David Gross6,
Ashley Gibson6, Jeanne Jellison7, Michael D. Sarap8, Tonia A. Bivens9, Tracy D. McGuire9,
Ann Scheck McAlearney3,4,5, Timothy R. Huerta3,4,5, Saurabh Rahurkar5, Electra D. Paskett3,4,5† and Mark Dignan2†
Abstract
Background: Colorectal cancer (CRC) screening rates are lower in Appalachian regions of the United States than in
non-Appalachian regions. Given the availability of various screening modalities, there is critical need for culturally
relevant interventions addressing multiple socioecological levels to reduce the regional CRC burden. In this report,
we describe the development and baseline findings from year 1 of “Accelerating Colorectal Cancer Screening
through Implementation Science (ACCSIS) in Appalachia,” a 5-year, National Cancer Institute Cancer MoonshotSM-
funded multilevel intervention (MLI) project to increase screening in Appalachian Kentucky and Ohio primary care
clinics.
Methods: Project development was theory-driven and included the establishment of both an external Scientific
Advisory Board and a Community Advisory Board to provide guidance in conducting formative activities in two
Appalachian counties: one in Kentucky and one in Ohio. Activities included identifying and describing the study
communities and primary care clinics, selecting appropriate evidence-based interventions (EBIs), and conducting a
pilot test of MLI strategies addressing patient, provider, clinic, and community needs.
(Continued on next page)
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Results: Key informant interviews identified multiple barriers to CRC screening, including fear of screening, test
results, and financial concerns (patient level); lack of time and competing priorities (provider level); lack of reminder
or tracking systems and staff burden (clinic level); and cultural issues, societal norms, and transportation (community
level). With this information, investigators then offered clinics a menu of EBIs and strategies to address barriers at
each level. Clinics selected individually tailored MLIs, including improvement of patient education materials,
provision of provider education (resulting in increased knowledge, p = .003), enhancement of electronic health
record (EHR) systems and development of clinic screening protocols, and implementation of community CRC
awareness events, all of which promoted stool-based screening (i.e., FIT or FIT-DNA). Variability among clinics,
including differences in EHR systems, was the most salient barrier to EBI implementation, particularly in terms of
tracking follow-up of positive screening results, whereas the development of clinic-wide screening protocols was
found to promote fidelity to EBI components.
Conclusions: Lessons learned from year 1 included increased recognition of variability among the clinics and how
they function, appreciation for clinic staff and provider workload, and development of strategies to utilize EHR
systems. These findings necessitated a modification of study design for subsequent years.
Trial registration: Trial NCT04427527 is registered at https://clinicaltrials.gov and was registered on June 11, 2020.
Keywords: Colorectal cancer, Multilevel interventions, Appalachia, Implementation
Contributions to the literature
 We describe the formation of a multicomponent multilevel
intervention (MLI) in rural Appalachian primary care clinics.
 Pilot year findings informed strategies and adaptations that
will be implemented during years 2 through 5 of the
multiyear intervention.
 Lessons learned from the first year of ACCSIS Appalachia can
inform other researchers seeking to implement evidence-
based colorectal cancer screening programs in low-resource,
rural settings.
Background
Colorectal cancer (CRC) is a significant public health
problem in several areas of the United States (U.S.), in-
cluding the Appalachian region [1]. Appalachia is a 13-
state, 205,000-square-mile region that ranges from the
southernmost counties in New York to northeastern
Mississippi [2]. While the region primarily follows the
Appalachian mountain range and is thus geographically
defined, the Appalachian Regional Commission has ex-
panded the federal designation of Appalachia to include
more distal locations, such as northeastern Ohio and
Mississippi, based on similar economic concerns and a
need to direct increased funding to non-core Appalach-
ian counties [3, 4]. More than 25 million people live in
Appalachia, where almost half of the area is rural and
most of the residents are White and non-Hispanic [5].
The Appalachian region has higher than average inci-
dence [5, 6] and mortality rates for CRC, with Kentucky
and Ohio experiencing some of the highest rates in the
nation [7]. Appalachian residents are more likely to have
lower incomes, higher poverty rates, lower levels of edu-
cation, higher unemployment rates, and poorer health
than non-Appalachian residents [4]. Given the signifi-
cant socioeconomic disparities across this geographically
unique, medically underserved region [1, 4], there is crit-
ical need for unique, culturally relevant interventions to
reduce the burden of CRC in Appalachia.
Although screening tests for CRC (e.g., colonoscopy,
sigmoidoscopy, stool tests) that can reduce both inci-
dence and mortality from CRC have been available, CRC
screening prevalence is lower in Appalachian regions of
Kentucky and Ohio as compared to non-Appalachian re-
gions [8]. Low CRC screening rates in Appalachia are as-
sociated with intrapersonal and health care provider-
related factors, but are also linked to state and commu-
nity factors such as access to health care and poverty
[9–11]. Factors such as high poverty rates, cultural and
religious considerations, and isolating geographical char-
acteristics [12] in rural Appalachia make safety net
clinics, health care providers, and community resources
critical sources of preventive care. Appalachians, in gen-
eral, live in tightly knit, rural communities where infor-
mation from non-local sources is carefully evaluated to
determine how it could be applied in the community
[13]. Though providers and health care delivery systems
have clear roles in recommending and providing access
to CRC screening, increased screening rates are also reli-
ant on positive community norms and patient factors
such as improved CRC knowledge and allaying fears sur-
rounding the screening tests [14, 15]. Thus, to engage
Appalachian populations, information needs to be pre-
sented via multiple channels as well as in ways and
through trusted sources that demonstrate understanding
of local interests, values, and communication styles [16].
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Multicomponent interventions that use a combination
of two or more approaches in three strategic areas—in-
creasing community demand, increasing community ac-
cess, and improving provider delivery of screening
services—have been found to be effective in increasing
CRC screening [17]. However, factors such as low per-
ceived risk, lack of knowledge about the need for screen-
ing and screening guidelines, belief that screening is not
necessary, provider distrust, and negative emotional per-
ceptions about screening such as embarrassment or fear
have each shown to be major patient-level barriers to
CRC screening in Appalachian populations [18–20]. At
the clinic level, barriers to receipt of screening include
lack of comprehensive educational materials and insuffi-
cient tracking systems to remind clinic staff to follow-up
with patients in need of screening [18]. Furthermore,
Appalachians have frequently encountered barriers such
as lack of physician recommendation as a reason for
having never received CRC screening [19], and medical
professionals identified limited time and high patient
volume as barriers to providing CRC screening, along
with acute medical concerns and procedural/reimburse-
ment issues [10, 15, 19]. Lastly, low rates of educational
attainment combined with fatalistic beliefs and fear of
cancer may contribute to the lack of discussion sur-
rounding CRC and screening [21]. Clearly, to reduce
CRC screening disparities, interventions must address
barriers at multiple socioecological levels [22], e.g., pa-
tient, provider, clinic and community, or multilevel in-
terventions (MLIs).
Researchers at the University of Kentucky (UK) and
Ohio State University (OSU) have conducted prior re-
search in Appalachia addressing each of these levels of
influence across Appalachian Kentucky and Ohio. From
2003 to 2018, they implemented the “Appalachia Com-
munity Cancer Network,” a National Cancer Institute
(NCI)-funded effort to address cancer disparities in the
region that included, among other programs, a faith-
based initiative to decrease cancer burden in rural Ken-
tucky and Ohio by reducing obesity and increasing can-
cer screening rates [23, 24]. Investigators at both
institutions have also implemented projects to reduce
CRC with an emphasis on clinic-level [10, 25–28],
provider-level [10], patient-level [29], and community-
level [30–33] factors. Although each project provided
new information about cancer control in Appalachia, the
projects also pointed to the need to provide interven-
tions that could simultaneously intervene at multiple
levels of influence rather than address individual levels
one at a time. This revised implementation approach,
therefore, guided development of the current project,
Accelerating Colorectal Cancer Screening through Im-
plementation Science in Appalachia (ACCSIS Appala-
chia), one of five Accelerating CRC Screening and
Follow-up through Implementation Science (ACCSIS)
programs funded by the NCI’s Cancer MoonshotSM ini-
tiative promoting acceleration of cancer research.
The overall aim of ACCSIS is to conduct multi-site,
coordinated, transdisciplinary research to evaluate and
improve colorectal cancer screening processes using im-
plementation science strategies. In this report, we de-
scribe the developmental process and year 1 pilot
findings for ACCSIS Appalachia and how we plan to test
our approach in a randomized controlled trial in 10 add-
itional counties in Appalachian Ohio and Kentucky dur-
ing years 2–5.
Methods
ACCSIS Appalachia was developed in two phases, and all
components of the project were approved by the institu-
tional review board of The Ohio State University prior to
engaging in project activities. Phase I focused on establish-
ing the project and conducting activities needed to de-
velop and test an MLI. These activities were conducted in
one Appalachian county in Kentucky and one county in
Appalachian Ohio and included a series of activities: (1)
identifying and describing the study communities and pri-
mary care clinics; (2) planning the MLI; and (3) conduct-
ing a pilot test of the MLI using customized clinic-specific
implementation strategies for EBIs at each level. As an
MLI project, the focus is on the patient, provider, clinic,
and community levels, with intervention delivery mainly
occurring within the primary care clinic setting and
community-level strategies often being supported by clinic
staff and efforts. The main outcomes from ACCSIS are
CRC screening, follow-up of abnormal tests, and referral
to care; data to assess outcomes will come from the elec-
tronic health record (EHR) systems of the participating
primary care clinics. Secondary outcomes include
community-level assessment of self-reported CRC screen-
ing collected from serial random-digit-dialed telephone
surveys. During year 1 activities, our primary foci included
assessment of factors (i.e., facilitators and barriers) affect-
ing implementation of evidence-based interventions (EBIs)
and pilot testing our research strategy for refinement prior
to full project trial implementation during Phase II in
years 2–5.
Theoretical framework
Development of the ACCSIS project was guided by three
theoretical frameworks. First, the Social Determinants of
Health Model provided the overall conceptual founda-
tion for the project. Second, the Model for the Analysis
of Population Health and Health Disparities, developed
by the Center for Population Health and Health Dispar-
ities (CPHHD), was used to understand not only the
multilevel factors that hinder and facilitate adherence to
CRC screening recommendations, but help understand
Kruse-Diehr et al. Implementation Science Communications            (2021) 2:51 Page 3 of 13
the relationships between levels [34]. As shown in Fig. 1,
the model focuses attention on factors termed “‘up-
stream” and “downstream” that contribute to health dis-
parities. This conceptual approach is particularly useful
in planning disparity-reducing interventions as it focuses
attention on community-level resources that could play
roles in reducing disparities as well as clinic- and
individual-level characteristics that may or may not be
modified by interventions.
Third, a model described by Proctor et al. [35] that
guides the implementation and evaluation of EBIs was
used to develop ACCSIS Appalachia. Specifically, imple-
mentation (e.g., fidelity, feasibility, acceptability and sus-
tainability), service (e.g., effectiveness), and client (e.g.,
satisfaction) outcomes will be assessed throughout the
implementation period. Data collection to measure these
outcomes is ongoing, and results will be reported in a
future manuscript. Application of each of these models
was guided by principles of Community-Based Participa-
tory Research (CBPR). CBPR provides a foundation that
focuses on including the community experiencing dis-
parities as a partner. Through CBPR, investigators are
led to understand disparities from the point of view of
the community and to consider intervention strategies
that the community wants and needs to address health
disparities.
Study population
Data for 2010–2014 showed that, compared to non-
Appalachian counties, Appalachian counties of Kentucky
and Ohio had higher CRC incidence (14.5% and 3.9%
difference, respectively) and mortality (26.4% and 10%
difference, respectively) [8]. With support from the Cen-
ters for Disease Control and Prevention, each state con-
ducts annual telephone surveys of health behaviors. This
survey is referred to as the Behavioral Risk Factor Sur-
veillance System (BRFSS) survey. Data from the BRFSS
surveys in 2014 and 2016 for Kentucky and Ohio
showed that screening rates were higher in non-
Appalachian counties, with the exception of stool blood
testing in Kentucky [8].
We selected 12 counties, six in Appalachian Kentucky
and six in Appalachian Ohio, to participate in ACCSIS
in Appalachia (Fig. 2). The counties were selected based
on a thorough review of cancer registry and BRFSS data,
socioeconomic indicators, and characteristics of primary
care clinics to ensure that counties (a) were representa-
tive of areas of central Appalachia that experience cancer
health disparities and high CRC incidence and mortality
rates and (b) had clinics that were willing and able to en-
gage in research, a determination facilitated by conversa-
tions between individual clinics and our project partners
at the Northeast Kentucky Area Health Education Cen-
ter (AHEC). To capture data about clinic and county
CRC burden, community and patient socio-demographic
profiles, and available health system and community
health resources, we carried out a multilevel assessment
in each county. Activities included conducting key in-
formant interviews, creating community profiles, identi-
fying clinic and community champions, and performing
Fig. 1 Model for analysis of population health and health disparities
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health clinic data inventories (e.g., baseline group-level
CRC screening and follow-up rates, EHR capabilities,
staff roles). Descriptive characteristics of the study coun-
ties are provided in Table 1 and characteristics of the
project clinics are shown in Table 2. As shown, the
population of the ACCSIS Appalachia counties experi-
ence low incomes and suboptimal CRC screening rates
that are lower than state and national rates.
External scientific advisory board
The research team identified five experts from outside
institutions with experience in community-based cancer
control research, CRC screening interventions, imple-
mentation science, and/or rural or Appalachian health
to participate in an external scientific advisory board
(ESAB) and provide input on project development and
implementation. ESAB members were provided with the
project protocol and data collection tools to review, and
they provided the ACCSIS team with recommendations
and suggested subsequent steps.
Community advisory board
Additionally, the ACCSIS team recruited community ad-
visory board (CAB) members from the identified project
counties in KY and OH. Participants were identified via
word of mouth, clinic recommendations, and key in-
formant interviews. Members include clinic and commu-
nity champions, community leaders, health department
and cooperative extension representatives, and commu-
nity health workers.
Formative clinic and community evaluation
After incorporating ESAB and CAB suggestions, investi-
gators conducted key informant interviews with commu-
nity members and clinical stakeholders to help develop a
locally relevant menu of EBIs from which pilot clinics
could select MLIs. Informed consent was obtained from
each key informant who completed a brief demographic
survey prior to beginning the discussion. Interviews were
audio-recorded and supplemented by handwritten notes.
For the community and clinical key informant groups,
the research team created a coding spreadsheet, identify-
ing high-level themes and overarching findings for each
broad category in the respective interview guide. Investi-
gators conducted interviews in-person, via telephone, or
via web-conferencing. Semi-structured interview guides,
informed by a review of the literature and the research
team’s prior experience in Appalachia, were used to
organize the interview discussions with the community
members and clinical stakeholders, respectively. Inter-
view guides concentrated on a SWOT (Strengths, Weak-
nesses, Opportunities, and Threats) analysis for CRC
screening at the patient, provider, clinic, and community
levels.
Community key informants were recruited using mul-
tiple strategies including personal email invitations and
referrals from existing partners (e.g., members of local
Fig. 2 Participating ACCSIS counties
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cancer coalitions). Recruited community members rep-
resented local agencies committed to serving area resi-
dents, including cooperative extension, community
health worker programs, local health departments, hos-
pitals, and cancer coalitions. The interview guide for
community members focused on perceptions of their
community’s health, socioeconomic status, culture, CRC
awareness, personal and community knowledge of CRC
screening tests, barriers to CRC screening in their com-
munities, community assets and/or programming that
Table 2 Characteristics of project clinics
Clinic counties Clinic type Clinic sizea % Medicaid # Providersb RUCA EHR
Ohio
Guernsey (Pilot) FQHC 396 21.5 4 5 eClinicalWorks
Adams FQHC 496 1.2 2 3 NextGen
Belmont FQHC 437 29.8 2 1 NextGen
Hocking FQHC 2641 17 6 7 eClinicalWorks
Lawrence FQHC 2837 43 4 1 eClinicalWorks
Morgan FQHC N/A 47 3 6 Epic
Kentucky
Lewis (Pilot) FQHC 1746 35 9 10 Athena
Lawrence Regional system 1449 32 4 2 Athena
Morgan Regional system 1654 29.2 4 10 Meditech
Breathitt FQHC 1061 54.1 7 8 Allscripts Pro
Carter Regional system 950 46 4 2 Meditech
Powell Regional system 558 31 4 5 Epic/Explorys
N/A not available
a # adults age 50–74; b includes full-time physicians, part-time physicians, nurse practitioners, and physicians’ assistants













US 125.1 48.9 66.3 50.8 103,202,874 $55,322 14.2 9.3
Kentucky 156.9 57.3 67.2 50.8 1,507,404
(35%)
$44,811 18.0 11.4
Breathitt 183.0 76.8 54.5 50.0 5225 (38%) $25,484 34.1 17.2
Carter 150.7 83.2 64.6 50.4 4281 (37%) $35.095 28.2 10.0
Lawrence 215.0 111.9 58.4 50.6 6024 (38%) $35,016 22.6 19.3
Lewis 158.6 78.7 61.7 50.1 5221 (38%) $29,088 27.2 20.1
Morgan 126.5 a 53.4 43.3 4910 (35%) $32,517 20.6 24.9
Powell 261.9 a 62.9 50.3 4564 (36%) $34,048 25.8 15.5
Ohio 130.0 54.3 65.1 51.2 4,044,691
(35%)
$50,674 14.7 8.1
Adams 174.3 84.7 64.3 50.6 10,396 (36%) $34,709 24.8 10.9
Belmont 111.8 65.7 62.7 49.6 27,495 (39%) $44,719 14.6 8.6
Guernsey 176.4 74.0 63.2 51.0 15,090 (38%) $41,566 19.0 8.6
Hocking 136.9 84.5 59.3 50.0 11,321 (39%) $43,382 15.9 8.7
Lawrence 141.7 61.2 64.7 51.4 22,926 (37%) $44,256 17.6 12.1
Morgan 126.2 74.2 64.5 50.2 5867 (39%) $38,941 19.9 11.9
a Suppressed due to small number of cases
bhttps://statecancerprofiles.cancer.gov/, per 100,000 population, 2010–2014, age 50+
chttps://statecancerprofiles.cancer.gov/, per 100,000 population, 2008–2010, age 50+
dhttps://www.socialexplorer.com/, 2010 (US Census Bureau)
ehttps://factfinder.census.gov/faces/nav/jsf/pages/index.xhtml, 2010 (US Census Bureau)
fhttps://factfinder.census.gov/faces/nav/jsf/pages/searchresults.xhtml?refresh=t, in 2016 inflation adjusted dollars (American Community Survey)
ghttps://factfinder.census.gov/faces/nav/jsf/pages/searchresults.xhtml?refresh=t, 2012–2016 (American Community Survey)
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could be leveraged to promote CRC screening, and pref-
erences for messaging and channels for delivery of
community-based CRC screening education.
Clinical stakeholders were individuals from participat-
ing health centers including doctors, nurses, certified
medical assistants, administrators, quality improvement
coordinators, and front desk staff. Similarly, the inter-
view guide for clinical stakeholders asked about percep-
tions of community- and patient-oriented challenges to
CRC screening, clinic- and provider-related practices
(e.g., patient education, recommended screening tests,
reminder systems, patient tracking, delivery of screening
results), and preferences for patient, provider, and com-
munity messaging and formats for CRC screening
education.
Phase I activities occurred during year 1 of the project
with Phase II activities scheduled for years 2 through 5.
Phase I activities were pilot tested in one Appalachian
Kentucky and one Appalachian Ohio county. Phase II
activities will include review and revision of the MLI ap-
proach tested in Phase I and evaluation of effectiveness
in a group randomized trial implemented in five add-
itional counties in Appalachian Kentucky and five add-
itional counties in Appalachian Ohio. Results from
Phase II will be reported in a future publication.
Results
Formative evaluation
A total of 12 CAB members in Kentucky and 10 in Ohio
were recruited to the project, and to date, we have held
four CAB meetings: in January 2019 (Kentucky), March
2019 (Ohio), May 2019 (Kentucky), and August 2019
(Ohio). Meetings provided CAB members with the op-
portunity to offer input and recommendations on the
proposed objectives and processes of Phase I of ACCSIS
Appalachia. Topics for CAB meetings included an over-
view of the initiative and themes reflected in key inform-
ant interviews, summary of clinic and community
intervention activities, and requests for feedback on tele-
phone survey materials, as well as suggestions for in-
creasing community participation and engagement at
future events.
Key informant interviews
We conducted interviews with 24 community members
(n = 13 in Kentucky, n = 11 in Ohio) and 51 clinical
stakeholders (n = 20 in Kentucky, n = 31 in Ohio) in the
12 intervention counties between February and May
2019. On average, the interviews took 45–60min. Key
informant interviews identified strengths such as pro-
viders encouraging CRC screening among patients and
positive and strong community connections, among
others. Common CRC screening barriers were described
at the (A) patient level (e.g., serious competing priorities,
fear of screening procedure and test results, financial
concerns); (B) provider level (e.g., time, competing prior-
ities); (C) clinic level (e.g., lack of reminder or tracking
system, staff burden); and (D) community level (e.g., cul-
tural issues, societal norms, transportation) [14, 36]. Op-
portunities included having a prevention-focused
message with CRC screening options and using accept-
able communication channels (e.g., social media, faith
community, low literacy print materials) that would le-
verage the importance of staying healthy for individuals’
families. Lastly, reported threats included negative anec-
dotal stories, loss of health insurance due to unemploy-
ment related to a cancer diagnosis, patient issues related
to insurance copayments, incongruence of screening
modality suggestions by providers, and ongoing clinic is-
sues with EHR capabilities.
Ultimately, the qualitative findings guided the research
team’s decision to create a menu of multilevel (i.e., pro-
vider/clinic, patient, community), evidence-based strat-
egies for clinics to choose from to implement in the year
1 pilot. In addition, pilot community events held in year
1 focused on provision of CRC and screening education
in a creative and engaging manner at a well-regarded
community location. For example, in Kentucky, the
ACCSIS team partnered with a federally qualified health
center (FQHC) and cooperative extension to host a
community luncheon that included an expert speaker
(i.e., nurse practitioner) and tours of an inflatable colon.
Subsequent discussions of community-level approaches
focused on the need to raise community awareness via
multiple communication methods, including health fairs
and mass communication mediums (e.g., newspapers,
billboards), that CRC is both preventable and treatable.
Pilot project implementation
After formative evaluation activities were complete, year
1 pilot project activities commenced in two clinics/com-
munities (i.e., one in Kentucky and one in Ohio). Project
staff and clinic champions conducted in-person imple-
mentation meetings with clinic staff and providers,
project team members, and any other interested stake-
holders with the goal of reviewing relevant national and
local CRC statistics, discussing themes identified in the
key informant interviews and environmental scans,
reviewing baseline CRC screening rates based on EHR
reports, describing the levels of implementation on
which to focus, and highlighting possible strategies for
each level. In Ohio, the pilot clinic chose patient educa-
tion (patient level), provider education (provider level),
and improving EHR reports and alerts and creating a
written pathway to care for CRC screening (clinic level)
as strategies to improve CRC screening in their patient
population. In Kentucky, the pilot clinic champion, in
consultation with clinic staff, selected patient education
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and fecal immunochemical testing (FIT) reminders/fol-
low-up (patient-level), feedback/assessment and provider
education (academic detailing), and developing a screen-
ing protocol and improving EHR reporting to increase
annual wellness visits (AWVs) (clinic level). Specific de-
tails about each intervention level are displayed in Table
3 and described in detail below.
Patient-level interventions
The Ohio pilot clinic implementation team chose
Healthy Colon, Healthy Life as the patient-level EBI
to implement in their clinic because it offered the po-
tential to reach those patients who do not present in
clinic at regular intervals [37]. Components included
the following: (1) a phone call from clinic staff to the
patient to confirm eligibility, identify stage of change,
and provide barrier counseling for CRC screening
(i.e., counseling about how to reduce barriers to
screening); (2) a mailed fecal occult blood test
(FOBT) accompanied by CRC screening educational
brochure and a letter from their provider encouraging
them to complete the at-home screening test; and (3)
a follow-up phone call from clinic staff to the patient
if the FOBT was not returned for processing. Adapta-
tions implemented by clinic staff included using the
FIT instead of the FOBT and using a Centers for Dis-
ease Control and Prevention (CDC) Screen for Life
brochure instead of the educational brochure used in
the sentinel study. Clinic staff also opted to display
CDC Screen for Life posters in their clinic space to
facilitate conversation around CRC screening and
begin to increase knowledge of the importance of
CRC screening. Similarly, the Kentucky clinic chose
to provide patient education using Screen for Life
materials. They chose to focus their patient-level edu-
cation on improving distribution and return of FIT.
Specifically, they mailed FIT reminder birthday
postcards to patients due for annual FIT, and a clinic
nurse created a demonstration video on how to
complete FIT and Cologuard, which was subsequently
publicized on the clinic’s social media pages.
Provider-level interventions
At the provider level, the Ohio clinic chose to imple-
ment a provider education EBI that focused on follow-
up of abnormal CRC screening tests, consistent with the
clinic’s goal of 100% follow-up [38]. Components in-
cluded two small group provider education sessions on
CRC and barriers to complete diagnostic evaluation (of-
fered 6 months apart), a pre-post survey to assess change
in knowledge, printed provider education materials, a
tailored letter and phone call from the trainer to the
provider, a practice-specific report about CRC screening,
and an education session evaluation. The clinic adapted
this EBI to focus provider education not only on follow-
up of abnormal CRC screening, but also education about
strategies to increase initial CRC screening. The educa-
tion was provided by OSU researchers who conducted
the hour-long session at the clinic during the clinic
lunch break (September 2019). Eight clinic/health system
providers and staff members attended. Pre- and post-
knowledge data were obtained from the providers: prior
to the education session, they averaged 15.3 ± 1.8 CRC
knowledge questions correct out of 20 which improved
to an average of 18.4 ± 1.5 correct following the educa-
tion session (p = 0.003).
Similarly, an intervention kickoff event was held by UK
researchers in November 2019 to present clinic staff de-
tails of their chosen EBIs, which included scheduled bian-
nual expert speakers to provide detail on high-level,
pertinent CRC screening topics for providers. The kickoff
presentation concluded with an educational session to as-
sist providers with motivating patients to complete CRC
screening. However, in previous discussions, the clinic
Table 3 Multilevel project activities in pilot counties
Guernsey (OH)—pair 1 Lewis (KY)—pair 1
Patient
level
• Telephone reminders for CRC screening (mailed FIT or ordered
Cologuard)
• FIT reminder postcards
• Screen for Life education
• FIT/Cologuard provider video• Provider letter with CRC Screen for Life pamphlet
Provider
level
• Assessment with feedback • Assessment with feedback
• Provider education • Provider education
• One-on-one call with gastroenterologist for education, encourage-
ment, provider barrier counseling
Clinic level • EHR alerts • CRC risk assessment added to EHR
• Annual Wellness Visit reminders/incentives
Community
level
• Community outreach events to promote screening—health fair;
farmer’s market; inflatable colon
• Community CRC screening billboards
• Community outreach events to promote screening—
community luncheon; inflatable colon
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indicated that provider knowledge of screening modalities
and guidelines was excellent and should not be the focus
of any provider education EBI sessions. Citing patient ad-
herence as a primary factor in low screening rates, the
Kentucky clinic chose to implement a provider education
EBI that focused on communication strategies providers
could utilize to motivate both willing and reluctant pa-
tients to complete CRC screening. The education session
was provided by UK researchers with expertise in CRC re-
search and communication strategies.
Clinic-level interventions
The pilot clinics in Kentucky and Ohio selected clinic-
level EBIs they felt would increase CRC screening and
were best suited to their needs. The Ohio clinic fine-tuned
their use of eClinicalWorks (eCW) to identify patients in
need of CRC screening and follow-up and created a writ-
ten pathway to clinical care for CRC screening and follow-
up of abnormal tests. The written pathway documented
the combination of the chosen EBIs and how their re-
spective components were assimilated into their existing
clinic operations. It also specified the process of identify-
ing patients eligible for screening, ensuring that patients
received a CRC screening recommendation (either in-
person or via mail), tracking completion of CRC screening
in eCW and referral follow-up, monitoring progress, and
making improvements, as needed.
The Kentucky clinic also developed a CRC screening
protocol to ensure implementation fidelity, and they de-
cided to focus on increasing the number of patients who
visit the clinic for annual wellness visits (AWV). In mak-
ing this decision to leverage AWVs to increase CRC
screening rates, the clinic pointed out the limited time
that providers have to discuss CRC with patients during
acute care visits, and also that AWVs are underutilized
by patients. AWVs provide the best opportunity and
time for providers to discuss CRC and other screenings
with patients in detail and use motivational communica-
tion techniques to encourage patients to follow through
and complete screening. To implement this strategy, the
clinic decided on a two-pronged approach: (1) at the pa-
tient level, the clinic will send birthday card reminders
to patients encouraging them to schedule AWVs; and
(2) at the provider/clinic level, the clinic will set goals
and provide incentives for providers and staff who in-
crease their respective AWV numbers.
Community-level interventions
The pilot clinics in both states chose to use the “inflat-
able colon” [39] to educate community members about
polyps, potential symptoms, and the importance of regu-
lar CRC screening. In Guernsey County, Ohio, the pilot
clinic partnered with a local regional medical center to
raise awareness about CRC and related screening [40].
Between May and July 2019, an inflatable walk-through
colon exhibit was set up at two community events in-
cluding a local farmer’s market and a festival. This inter-
active format included guided tours of the colon exhibit
by health care professionals to educate 70 lay commu-
nity members about prevention and early detection of
CRC. The participants received a card with CRC cancer
screening recommendations and contact information for
free or reduced cost screening available in their county.
Local media coverage of these events included local
radio station and newspaper, along with a video of a
guided tour of the colon exhibit posted on Facebook.
A similar event was held in Lewis County, Kentucky,
in May 2019. The outreach event was held in conjunc-
tion with the local county extension office. The event in-
cluded a presentation from a clinic provider on how to
complete FIT and Cologuard tests, a healthy cooking
demonstration, a testimonial from a community member
about her personal colonoscopy experience, and guided
tours of the inflatable colon. Forty-six community mem-
bers attended the event. Additionally, to help reach pa-
tients who may not visit the clinic regularly, members of
the Kentucky CAB in the pilot county decided to use
mass media to deliver a message that CRC is “prevent-
able, treatable, and beatable.” To that end, a billboard
was collaboratively designed with input from Kentucky
ACCSIS project team members, clinic staff, and univer-
sity marketing staff. The billboard was erected in De-
cember 2019 in a high-visibility location along a main
highway, and it included the aforementioned simple
message; the logos of the university, project, and local
clinic; a contact phone number for community members
to inquire about screening; and a photo of a known
practitioner from the clinic.
Study design modification
Throughout the course of these multilevel program ac-
tivities, it became apparent that supporting clinics
throughout EBI implementation requires more resources
than we initially anticipated. We originally planned on
evaluating our MLI using a group randomized trial. Two
counties per state would be randomized to an early
intervention arm, and two counties would be random-
ized to a delayed intervention arm which would receive
our MLI 12months later. Counties in each study arm
would experience a 12-month active intervention period
and then be observed for sustainability of the MLI for ei-
ther 12 or 24 months depending on the arm. However,
based on our experience in the pilot year, the design was
altered to introduce the intervention in a staggered fash-
ion (Table 4).
Within each state, counties will be paired according to
patient volume of the participating clinics in each
county. The pair containing the pilot county (pair 1) will
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be the first to receive the intervention with the order of
the other pairs (pairs 2 and 3) randomly determined.
Study group (early, delayed intervention) will also be
randomly assigned within pairs 2 and 3. Thus, across the
two states, we will have eight counties that will be ran-
domized to study group and four whose group assign-
ment will not be randomly determined. Figure 3
provides a detailed look at the study timeline in pair 1.
The county assigned to the early intervention group will
receive the MLI at the beginning of phase II and the
other county will receive the program 12months later
(delayed group). At 12 months (end of the Phase I) and
24months (end of Active Implementation in the Early
Intervention group), we will obtain clinic-level and
county-level CRC screening rates using the EHRs and
county-level behavioral assessment survey, respectively.
In addition to at 12 and 24 months, screening rates will
be collected at baseline (i.e., month 1), and 36- and 49-
month time periods to assess trends. The timelines for
pairs 2 and 3 are similar, though the sustainability pe-
riods are shorter since the MLI is introduced later in the
study. To minimize potential contamination from com-
munity activities, we intentionally selected project
counties that were either non-adjacent or that had
unique travel patterns (i.e., common cities where resi-
dents were likely to seek out services such as restaurants,
activities, and medical care) that did not overlap with
other study counties. Furthermore, we plan to collect
survey data from control clinics at the end of the inter-
vention to account for any potential contamination
among residents of different project counties.
Lastly, our pilot work indicated that a change in pri-
mary outcomes was necessary. Originally, our primary
outcome was the county-level CRC screening rate which
would be determined using telephone surveys conducted
every 12 months in each county. However, most of the
intervention activities occurred in the clinics, not in
county-wide community settings, so assessing county-
level CRC screening rates did not seem to reflect the ef-
fects of our partners’ greatest efforts. Given our study
design, we would expect stronger effects on clinic-level
rates than county-level rates which may demonstrate
lagged effects due to the time required for the interven-
tion to permeate from the clinic to the community. We
also realized during the pilot period that in order to
reach our target sample size of 100 participants per
Table 4 Intervention timeline for each state
5/2019 10/2019 5/2020 10/2020 5/2021 10/2021 5/2022 10/2022 5/2023
Pair 1 County 1a AI AI AI/S S S S S S S
County 2 C C AI AI AI/S S S S S
Pair 2 County 3 AI AI AI/S S S S S S
County 4 C C AI AI AI/S S S S
Pair 3 County 5 AI AI AI/S S S
County 6 C C AI AI AI/S
AI active intervention period, C control period, S sustainability period, AI/S AI ends and S begins
aPilot
Fig. 3 Study schema
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county, data collection required more time than antici-
pated and would span both the active intervention and
sustainability period in the early intervention arm as well
as the control and active intervention periods in the de-
layed intervention arm, which is not ideal for estimating
an intervention effect. As a result, we changed our pri-
mary outcome to clinic-level CRC screening rates deter-
mined via EHR. Since exact screening dates are available
in the EHR, we can easily determine the number of pa-
tients screened during the control, active intervention,
and sustainability periods.
Discussion
In this report, we have described our experiences during
year 1 of a 5-year project that will deliver an MLI to in-
crease CRC screening and follow-up in underserved
areas of the U.S., specifically Appalachian Kentucky and
Appalachian Ohio. Preliminary tasks included selecting
rural primary care sites in Appalachian counties and de-
veloping relationships to serve as a foundation for imple-
menting the program. A theory-guided approach used
by the investigators focused on careful assessment of
community and clinic assets and barriers that would in-
fluence intervention implementation. The structure and
management of the primary care clinics, the EHRs that
they use, and community context were important drivers
of progress in developing the project. The pilot phase
proceeded as planned and provided important informa-
tion on how to move forward with the full-scale trial.
A strength of the process was that the investigators
have extensive history of working in partnership with
Appalachian communities [10, 23–33] and have thus
developed sustained, trusting relationships. This his-
tory has included extensive travel and face-to-face
meetings with local residents where cultural nuances
were made clear. For example, through these meet-
ings, the investigators learned about sensitivity to cul-
tural stereotypes and assumptions that are often made
about the region and its people. Gaining an under-
standing of the culture, issues experienced by the
communities, and barriers clinics in these regions are
facing contributed to the success of the pilot phase.
The information gathered in piloting the intervention
approach in two clinics informed the structure and
development of the full implementation of the pro-
gram coming in years 2 through 5.
One of the primary lessons learned was the extent of
the challenges associated with the range of administra-
tive structures of the primary care clinics. Although
community structures were relatively uniform and char-
acteristic of rural Appalachia, the primary care clinics
had distinctly different structures. Several clinics are
FQHCs and others are satellite primary care clinics of
regional hospitals. The satellite primary care clinics are
governed by the corporate policies of the regional hospi-
tals and have varying degrees of decision-making author-
ity. Additionally, as health care delivery in rural areas
has been in flux in recent years [41], change has
occurred in the structures of health care corporations
since the project began. The FQHCs, on the other hand,
are independent Health Resources and Services
Administration-funded entities that make their own de-
cisions. This type of variability necessitates that re-
searchers working in Appalachian primary care clinics
be flexible with clinic partners, including encouraging
clinic champions to adapt EBI strategies to reflect re-
gional and clinical contextual needs [42, 43]. These lo-
cally relevant adaptations, in turn, can increase clinic
capacity for promoting CRC screening and thus improve
the likelihood of overall EBI success [44].
Finally, differences in EHRs among the clinics also pre-
sented challenges. A total of eight different EHRs are
currently used among the 12 participating clinics and
the clinics engaging in year 1 each had different EHRs.
Further, none of the clinic partners maintain on-site
technical support for their EHR. As a result, while clinics
can generate pre-defined reports, they frequently have
no ability to customize those reports or change the sys-
tems to facilitate the intervention. Such changes report-
edly require the use of consultants who function
remotely from the clinic. Thus, efforts to obtain screen-
ing data or add intervention components through the
clinic EHRs were problematic and required extensive in-
teractions with our staff, including health IT experts
from the universities. Due to privacy concerns and insti-
tutional health system policies, efforts to assist clinic and
health system staff with this activity were not successful.
Given that underuse of EHR functionality tends to be
more prevalent in rural areas [45], researchers working
with rural independent primary care facilities (rather
than clinics within an individual health care system)
should prepare well in advance for possible technological
limitations and consider methods by which they might
mitigate these limitations, such as consulting with uni-
versity IT resources during project planning to ensure
clinics have appropriate technical assistance when
necessary.
Although all counties and clinics participating in
the project are in Appalachian Kentucky and Appa-
lachian Ohio, there are important differences in each
clinic and county that may affect CRC screening and
follow-up of abnormal findings. Health care in the
counties is provided by primary care practices and ac-
cess to specialty care such as colonoscopy, surgery,
and medical oncology is only available in large popu-
lation centers. Thus, for most community residents,
local access to CRC screening is limited to stool
blood testing by FOBT, FIT, or Cologuard. We have
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plans to work with clinics to address these
limitations.
Conclusions
The experience gained through working with the pilot
clinics in year 1 of the project provided significant les-
sons, including recognition of variability among the pri-
mary care clinics and how they function, appreciation
for the workload of the providers and clinic staff, and
understanding of barriers to gaining access to EHR data
for evaluation. The experience also led to recognition
that the resources needed to implement the intervention
with fidelity required revision of the study design. Col-
lectively, this formative research has informed project
activities and implementation strategies for years 2
through 5 of ACCSIS Appalachia to ultimately address
the problem of CRC disparities in Appalachia.
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